---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-049300"
form_type: "8-K"
ticker: "ABVC"
cik: "0001173313"
company_name: "ABVC BIOPHARMA, INC."
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-13T23:44:54.939250+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ABVC BioPharma appoints Dr. T.S. Jiang as CSO after Dr. King resigns

## Summary
- Dr. Richard King resigned as Chief Scientific Officer effective June 13, 2023.
- Resignation not due to any disagreement with company operations, policies, or practices.
- Board appointed Dr. Tsung-Shann (T.S.) Jiang, current Chief Strategy Officer and director, as replacement CSO.

## SEC filing metadata
- accession: 0001213900-23-049300
- form_type: 8-K
- ticker: ABVC
- cik: 0001173313
- company_name: ABVC BIOPHARMA, INC.
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1173313/000121390023049300/0001213900-23-049300-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1173313/000121390023049300/ea180383-8k_abvcbiopharm.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-049300
- JSON: https://secwatch.observer/filing/0001213900-23-049300.json
- Plain text: https://secwatch.observer/filing/0001213900-23-049300.txt

## Key facts
- Executive change
  Dr. Richard King resigned as Chief Scientific Officer at ABVC BIOPHARMA, INC..
  - Action: resigned
  - Role: Chief Scientific Officer
  source text: Dr. Richard King, the Company’s Chief Scientific Officer (“CSO”) of ABVC BioPharma, Inc. (the “Company”), notified the Company of his resignation, effective June 13, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390023049300/0001213900-23-049300-index.htm
- Executive change
  Dr. Tsung-Shann (T.S.) Jiang was appointed as Chief Scientific Officer at ABVC BIOPHARMA, INC..
  - Action: appointed
  - Role: Chief Scientific Officer
  source text: The Company’s board of directors appointed Dr. Tsung-Shann (T.S.) Jiang to replace Dr. King as the Company’s CSO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1173313/000121390023049300/0001213900-23-049300-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.